Skip to main content

Table 2 Detection of SARS-CoV-2 and specific antibody levels in all COVID-19 patients (n = 36)

From: Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses

ID

SARS-CoV-2 PCR

(Ct value)

SARS-CoV-2 culture

Anti-SARS-CoV-2 IgG titers

Neutralizing antibody titers

Days after onset of symptom

NPH

Sputum

serum

NPH

Sputum

1

19

21

neg

pos

pos

< 20

< 10

16

2

24

28

neg

pos

neg

< 20

< 10

9

3a

25

19

neg

pos

neg

40

< 10

9

4a

26

20

neg

pos

neg

40

10

11

5

32

24

neg

neg

neg

40

10

9

6

neg

23

neg

neg

neg

40

10

10

7d

33

n/a

neg

neg

n/a

320

10

9

8b

28

37

38

neg

neg

160

15

10

9

neg

n/a

neg

neg

n/a

320

30

11

10

neg

neg

neg

neg

neg

640

30

12

11

neg

n/a

neg

neg

n/a

40

40

10

12a

33

n/a

neg

neg

n/a

1280

40

11

13

34

32

neg

neg

negf

1280

40

20

14a

28

n/a

neg

neg

neg

640

60

14

15

neg

31

neg

neg

neg

640

60

18

16

35

neg

neg

neg

neg

1280

60

15

17

35

neg

36

neg

neg

1280

60

48

18a

30

29

neg

neg

neg

2560

60

28

19a

neg

neg

neg

neg

nege

2560

60

30

20

neg

36

neg

neg

neg

640

80

53

21

neg

34

neg

neg

neg

1280

80

43

22c

neg

neg

38

neg

neg

2560

80

18

23a,d

26

20

neg

neg

neg

320

120

9

24

neg

36

neg

neg

neg

2560

120

39

25

neg

neg

neg

neg

neg

2560

120

18

26a

neg

neg

neg

neg

neg

2560

120

21

27a

neg

neg

neg

neg

neg

1280

160

21

28

neg

27

neg

neg

neg

1280

160

43

29a

neg

neg

neg

neg

n/a

1280

240

21

30

neg

28

neg

neg

neg

1280

240

14

31

neg

28

neg

neg

nege

1280

240

27

32

neg

neg

neg

neg

neg

2560

240

20

33

neg

neg

neg

neg

neg

2560

240

37

34a,b

neg

n/a

neg

neg

n/a

1280

320

22

35

neg

32

neg

neg

neg

2560

320

19

36a

neg

neg

neg

neg

neg

1280

560

26

  1. Abbreviation: neg negative, NPH nasopharynx, pos positive
  2. atreatment with corticosteroids, btreatment with tociluzimab, ctreatment with anakinra, dremdesivir treatment
  3. ePositive for herpes simplex 1 in PCR
  4. fPostive CPE in culture, negative for SARS-CoV-2, herpes simples 1 and 2, cytomegalovirus, adenovirus, bocavirus, enterovirus, metapneumovirus, parainfluenzavirus and rhinovirus